iBio, Inc. is a biopharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases. It has a pipeline of proprietary products in preclinical development, including sub-unit vaccines directed against both seasonal and pandemic influenza, sub-unit vaccines for prevention of anthrax and plague, sub-unit vaccines for treatment of HPV infections, therapeutic antibodies for treatment of anthrax and antibodies for prevention, treatment and diagnosis of pandemic influenza
Partial Data by Infogroup (c) 2024. All rights reserved.